US Patent Issued to Pfizer on Sept. 15 for "Cell culture process for producing RSV F protein" (Massachusetts, New York, California, New Jersey Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,231, issued on Sept. 15, was assigned to Pfizer Inc. (New York).

"Cell culture process for producing RSV F protein" was invented by Shelby Hutchins Breen (North Andover, Mass.), Cameron Albert Harrington (Somerville, Mass.), Michaela Evelina Jacobs (San Diego), Jason Arnold Lotvin (West Nyack, N.Y.), Bhanu Chandra Mulukutla (Tewksbury, Mass.), David Stead (Weehawken, N.J.) and Madhuresh Sumit (Andover, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to methods for producing an RSV F protein trimer in a fed batch cell culture."

The patent was filed on Sept. 30, 2021, under Application No. 18/247,565.

*For further informa...